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ABSTRACT 
 
Objective: To explore how caregivers are involved in making treatment decisions for older 
people living with dementia and a new diagnosis of cancer. 
Method: A systematic review of PubMed, CINAHL, PsycINFO, Web of Science and Scopus 
databases was conducted. Studies recruiting formal or informal caregivers for older people 
with dementia and a diagnosis of cancer were considered for inclusion.   
Results: Of 1761 articles screened, 36 full texts were assessed for eligibility and 6 were 
included in the review. This review has identified that health care professionals (HCPs) are 
often unaware of the co-existence or severity of dementia in cancer patients, and therefore 
fail to properly address care needs as a result. While caregivers are relied on to help make 
decisions, they have unmet information needs and feel excluded from decision-making.  
Conclusion: Treatment decision-making in the context of older adults with dementia and a 
new diagnosis of cancer needs further research. This will help HCPs to understand their 
needs and improve the experience of decision-making for both caregivers and the people that 
they care for.  
KEYWORDS:  
Caregivers, Dementia, Decision-Making, Neoplasms, Proxy 
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1. BACKGROUND 
 
Over the past 25 years there has been a substantial growth in the older adult population, who 
now represent the fastest growing demographic in the U.K. (1). Older adults are now living 
much longer with advanced stages of age-related co-morbidities, such as cognitive 
impairment, and have an increased vulnerability to age-related disease and cancers. The 
global incidence of dementia is approximately 10 million new cases each year (2), with 
around 850,000 people diagnosed with some form of dementia in the U.K. (3) . The 
demographic outlook suggests that by 2021 an estimated 1,000,000 people will be living with 
some form of dementia. Advancing age is also a significant risk factor for cancer, with over 
half of all cancers being diagnosed in the over 70 age group each year in the U.K. (4). 
 
Dementia is a disease characterized by a progressive set of conditions that include loss of 
judgment, reasoning ability and memory; all of which will impair capacity to make informed 
decisions (5). The scope of dementia impacts so much more than just memory; it can impair 
language, perception, and the ability to undertake daily tasks without additional care and 
assistance. Together, these changes over time can place a profound burden on their family 
and caregivers, especially in the later stages of dementia, which will increase the need for 
care services, psycho-social support and assistance with treatment decision-making (6). 
Dementia severity and the trajectory of functional decline vary from person-to-person, 
meaning that older adults who live with this condition are highly heterogeneous. Some people 
with memory problems may be living without a formal diagnosis, or may avoid visiting their 
GP through fear and stigma of the disease (7). Whilst some older adults in the early stages of 
the disease may have mild impairment and can still make informed decisions; others in the 
severe or later stages of dementia will rely on the input of others, such as their family and 
caregivers (8). 
 
Caregivers can either be formally or informally appointed to help make decisions on behalf of 
a person who lacks the capacity to make their own decisions (9). Some caregivers may be 
legally appointed to this role while the individual still has capacity, whilst others may take on 
this role suddenly or gradually over time. Under current U.K. law, caregivers must have 
lasting power of attorney (LPA) for health and welfare in order to make treatment related 
decisions on behalf of another person. The role of the caregiver in this scenario is to elicit the 
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preferences of the person living with dementia and navigate which treatments are in their best 
interests (10). In the literature this is often referred to as proxy or surrogate decision-making.  
 
As the ageing process varies, some older adults may be considered fitter than others, and able 
to withstand different levels of treatment. Treatments for new cancer diagnoses should 
therefore be tailored and take into account any existing co-morbidities and treatment regimes 
(6). For older adults with normal cognition, following routine clinical investigations and 
diagnosis there will be a discussion about the pros and cons of treatment options together 
with the treating clinician before making an informed decision. Family, caregivers and 
friends may be involved in the consultation and offer their support, but ultimately, the patient 
will make this decision and give their consent to treatment. 
 
For people living with dementia the process of diagnosis may differ significantly to those 
with no cognitive impairment; screening opportunities may be limited, and undergoing 
diagnostic investigations may present a burden to the person living with dementia and their 
caregiver (11). Clinical investigations such as scans and biopsies may also be more 
challenging. People with dementia may also lack the capacity to understand the treatment 
options available, and information may need to be adapted or presented in a manner adapted 
to their cognitive capacity. The language deficits frequently associated with severe dementia 
may mean that some people living with the disease are not able to communicate their 
decision and give verbal consent to treatment. Caregiver involvement may therefore be 
needed to interpret WKH SDWLHQW¶V ZLVKHV DQG KHOS JXLGH WKH consultant towards a treatment 
plan that takes into account the wishes of the patient and is in their best interests.  
 
In the U.K., there are ethical frameworks that guide treatment decision-making for both 
caregivers and clinicians (12), and there are legal guidelines that help individuals state their 
treatment preferences whilst they still have capacity to do so (13). The concepts of autonomy 
and informed decision-making are paramount, and should be upheld in cases where treatment 
preferences have been stated in an advance directive (AD) before the person lost capacity 
(14). An AD designates instructions for future medical treatment or for a decision-maker with 
LPA to act on their behalf. Advance decisions are useful because they allow people to retain 
autonomy over their future treatment, particularly in cases where there is no opportunity to 
have a discussion about treatments. The reality is that not all people are able to state their 
preferences in advance of losing capacity, and may not always have an AD in place (15). As 
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a result of these issues, caregivers and clinicians may be presented with ambiguous 
circumstances where the preferences of the person they care for are unknown or have not 
been previously stated. In cases where it is not possible to determine which treatments the 
patient might decide for himself or herself, the principle of best interests should be used and a 
best interest meeting may be held; involving clinicians, caregivers, individuals with LPA and 
sometimes even the person with dementia themselves.  
 
Little is currently known about how caregivers are involved in making cancer treatment 
decisions for the older, cognitively impaired population. Previous reviews have struggled to 
identify many studies that have directly explored the experiences of people with dementia 
and their caregivers in this context (16). A recent review by Hopkinson and colleagues, which 
sought to find out about the experiences of people with cancer and dementia, found that 
people with dementia were more likely to have a delayed diagnosis and receive fewer 
treatments compared with cancer patient who did not have dementia (17).  
 
The aim of this review was to address a gap in knowledge by exploring how caregivers are 
involved in making cancer treatment decisions for older people with dementia who receive a 
new diagnosis of cancer. 
2. METHODS 
2.1.SEARCH QUESTION 
 
How are caregivers involved in making treatment decisions for older people with dementia 
and a new diagnosis of cancer? 
2.2.SEARCH STRATEGY 
 
A comprehensive search of the literature was conducted in accordance with PRISMA 
guidelines (18) between June and September 2018, and revised again in January 2019. The 
following databases were searched: CINAHL, PubMed (via MEDLINE), PsycINFO, Scopus 
and Web of Science. Hand-searching reference lists and the grey literature also obtained 
references. The search was limited to the English language. Given the nature of the research 
TXHVWLRQDQDGDSWHG³3&2´IUDPHZRUN(19) was used for this review. A broad range of key 
search terms and MeSH topics were used based DURXQG WKH WRSLFV RI ³GHFLVLRQ-PDNLQJ´
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³FDUHJLYHUV´³GHPHQWLD´DQG³cancer´A combination of free text searches and MeSH terms 
were used to identify articles. An example of the search strategy for PubMed (via 
MEDLINE) is shown in Appendix 1. 
2.3.ELIGIBILITY CRITERIA 
 
The search aimed to identify qualitative, quantitative or mixed method studies that recruited 
caregivers (both informal and formal) for people living with dementia. Studies were included 
if they made reference to cancer treatment decision-making for older people living with 
dementia. This included studies that observed treatment discussions in consultations and 
caregiver perspectives on hypothetical treatment scenarios. Reviews, letters, case studies, 
editorials, and conference abstracts were excluded. Studies were limited to those that focused 
on older adults (>60), as this age is widely accepted as a lower cut-off for chronological older 
age (20). 
2.4.QUALITY APPRAISAL 
 
Two reviewers (CM and AS) discussed and selected the articles included in this review. The 
rationale for including studies with either a mixed method, qualitative or quantitative design 
was that this would allow a broad understanding of the research topic. Search results were 
imported to Endnote for screening and full text retrieval. Studies were selected for this review 
using a two-step process; articles were first screened by title and abstract to determine 
relevance to the review. The PRISMA search strategy (18) was used to filter articles and 
remove any duplicates (Figure 1). Full text articles were then retrieved to assess relevance 
against the inclusion criteria and then independently reviewed.   
 
The Mixed Method Appraisal Tool (MMAT) (21, 22) quality checklist was used to appraise 
each study. The MMAT criteria include 2 screening questions, and 19 items to appraise five 
types of study (qualitative, quantitative randomized controlled trials, quantitative non-
randomized, quantitative descriptive, and mixed methods). Quality assessment scores were 
calculated for each study using the MMAT score, ranging from one criteria met (25%) to all 
criteria met (100%).  No study was excluded on the basis of quality assessment as the authors 
chose to include studies that represented the small amount of literature exploring decision-
making for people with dementia and cancer. However, for qualitative studies, the question 
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³( ,VDSSURSULDWH FRQVLGHUDWLRQJLYHQ WRKRZ ILQGLQJV UHODWH WR UHVHDUFKHUV¶ LQIOXHQFH
HJWKURXJKWKHLULQWHUDFWLRQVZLWKSDUWLFLSDQWV"´was unclear or not always addressed. 
2.5.ANALYSIS 
 
 Thematic analysis was undertaken in accordance with the Framework approach (23, 24). 
This process involved coding the key findings across studies, and then developing themes, 
which were then summarized within a framework matrix. Reviewing the matrix generated the 
final themes. The analysis was guided by an interpretivist approach. 
3. RESULTS 
 
The search produced a total of 1935 results. Of these, 174 duplicates were removed, and 1725 
were excluded, as they did not meet the inclusion criteria. The remaining 36 articles were 
retrieved for full text review and 6 of these were deemed suitable for inclusion. The term 
µFDUHJLYHU¶ has been used throughout this paper to represent carers and informal caregivers. 
Health care provider (HCP) has been used as a comprehensive term for the treating clinician, 
consultant or oncology staff. 
3.1.STUDY CHARACTERISTICS  
 
Of the six studies included (Table 1), five were conducted in the U.K. and one in the USA. 
One study used a quantitative cross sectional design (25) and five studies used a qualitative 
design (26-30). Two studies explored treatment decision-making in the context of 
hypothetical treatment scenarios (25, 26), three studies observed prospective treatment 
decision-making in clinical scenarios (27-29) and one study interviewed patients and 
caregivers who were reflecting retrospectively on the cancer diagnosis and treatment 
decision-making (30).  
 
All six studies used semi-structured interviews (face-to-face or telephone) with 
informal/familial caregivers to collect primary data. Five qualitative studies used a 
framework, thematic or narrative analysis (26-30) and one study used descriptive statistics 
(25). Two studies observed or interviewed HCPs in addition to caregivers (27, 28) and four 
studies also included the views of people with dementia (25, 27, 28, 30).  
 
  
This article is protected by copyright. All rights reserved. 
Four studies specified a clinical diagnosis of dementia for the patient being cared for in their 
inclusion criteria (25, 28-30), and one study included caregivers for patients with a memory 
problem, as judged by the HCP and patient (27). Five studies recruited participants from 
either cancer clinics (27-30) or memory clinics (25), and one study recruited caregivers from 
a dementia registry (26).   
 
Three studies reported their sampling method as purposive (28-30), while others were unclear 
(25-27). The sample sizes of interviewees reported in the qualitative studies ranged from 6 to 
60 patient-caregiver dyads (25, 27, 30), and 7 to 23 caregivers interviewed individually (26, 
28, 29). Two studies interviewed patients with dementia individually in their case sample (28, 
30). 
 
7KHPDWLF DQDO\VLVXVLQJHVWDEOLVKHG WKHRULVWV VXFKDV:ROFRWW¶V IUDPHZRUN DQG%UDXQDQG
&ODUNH¶VWKHPDWLFDQDO\VLVwere used in three qualitative studies (27, 28, 30) and 5LHVVPDQ¶V
narrative approach was used in one study (29). One study measured responses using caregiver 
specific questionnaires, such as the Quality of Carer Patient Relationship questionnaire 
(QCPR) (25).  
3.2.FINDINGS 
 
Due to the study design of selected papers, a meta-analysis was not possible. Data have been 
categorized into three themes that interplay with the caregiver experience of making 
treatment decisions: (1) HCP dementia awareness and knowledge in the clinical consultation; 
(2) Treatment decision-making discussions, information and communication needs; (3) The 
caregiver role and the caregiver-patient relationship. 
3.2.1. HCP DEMENTIA AWARENESS AND KNOWLEDGE IN THE CLINICAL 
CONSULTATION 
 
Following screening, clinical investigation and diagnosis, the initial cancer consultation was 
often the first point in the cancer treatment pathway where HCPs met with patients and their 
caregivers to discuss treatment options. Four studies explored the experiences of caregivers 
and HCPs in the cancer setting through observation of consultations (27) and semi-structured 
interviews (27-29). Caregivers in one study reflected back on the consultation where the 
person living with dementia received their cancer diagnosis (30). 
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Having access to detailed patient information, such as past medical history, comorbidities and 
cognition level enabled +&3¶V to plan sufficient time for discussion in the consultation (28). 
McWilliams and colleagues noted that cognition status was not always known to the HCP in 
advance of the consultation (28), and dementia was also infrequently documented in the 
SDWLHQW¶V referral information or medical records in the study led by Courtier and colleagues 
(27). In both studies, the identification of memory problems was often reliant on caregiver 
disclosures (27, 28). As a result of this unawareness, one caregiver described a scenario 
where the HCP failed to acknowledge KLV ZLIH¶V GLVWUHVV ZKHQ XQGHUJRLQJ D FOLQLFDO
investigation, alongside failing to fully explain what the procedure entailed and what was 
expected (30).   
 
In most studies, the caregiver accompanied the patient in the consultation where treatment 
options were discussed. In the study led by Witham and colleagues, one caregiver described a 
series of scenarios that led to missed appointments where the patient attended their 
appointment unassisted; this was due to unclear signage in the clinic and an absence of staff 
to guide the patient once in the hospital (29). The cognitively impaired patient also had a 
coexisting hearing problem, and was unable to hear his name being called. Another caregiver 
in this study highlighted the logistics of transporting people with dementia who live on their 
own in the community to their appointments. A scenario was recalled where the patient's 
erratic sleep pattern was incompatible with the arranged transport pick-up time. This meant 
that without prompts, the patient would miss their transport to the appointment (29). 
 
In the context of consultation discussions, caregivers felt that decisions had been made by 
+&3¶VSULRUWRWKHLQLWLDOFRQVXOWDWLRQ(28) and relayed feeling excluded from decisions (29). 
&DUHJLYHUVLQ0F:LOOLDPVDQGFROOHDJXHV¶VWXG\KLJKOLJKWHGWKHXQFHUWDLQWLHVDURXQGWDNLQJ
consent from people with dementia to undergo clinical investigations and the level of 
responsibility expected from caregivers (30). Caregivers also highlighted the need for 
additional appointments, where treatment plans could be discussed further, independently 
from the patient (29).  
 
Caregivers in the study led by Courtier and colleagues noted that the cancer consultation had 
a tendency to focus primarily on cancer treatments, rather than cognition-related problems 
(27). This subsequently led to memory problems remaining undiscovered. In two studies, it 
was noted that patients would often underplay memory problems (27) and dispute their 
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inability to cope with treatment as a result of their impairment (29). Cancer diagnostic 
investigations were often delayed due to the combination of limited HCP awareness of 
memory problems and a failure to detect the signs associated with dementia (28). The lack of 
timely organisation of support for people with memory problems was therefore an issue (27, 
28).  
 
Two studies highlighted that dementia awareness training for cancer clinicians was needed 
(27, 28). The reasons for this included a lack of awareness of the impact that dementia may 
have on cancer screening (28) and the potential for interaction between the patients' dementia 
symptoms and cancer treatment (27). %HLQJXQDZDUHRIWKHSDWLHQWV¶DELOLW\WRJLYHLQIRUPHG
FRQVHQW PD\ UHVXOW LQ +&3V WDNLQJ WKH UHIXVDO RI WUHDWPHQW DW µIDFH YDOXH¶ DV noted by a 
caregiver in the study by Witham et al (29).  Witham and colleagues describe one situation 
where a patient failed to complete their radiotherapy treatment due to refusing to attend 
appointments. This scenario was a result of the HCP failing to acknowledge that the person 
with dementia lacked the capacity to make informed decisions. In examples where HCPs 
were made aware of cognition problems in the patient, there was an uncertainty on how to 
best support them (27). 
 
,Q6P\WK¶V(26) study of breast screening and treatment preferences, caregiver decisions were 
found to be influenced by HCPs in regards to continued breast imaging; with a tendency to 
continue screening based on the clinician¶V recommendations. Witham and colleagues also 
noted the dominance of the HCPs' knowledge in the consultation, through a scenario where a 
FDUHJLYHU UHOD\HG IHHOLQJ WKDW WKHLU MXGJPHQW RI WKH SDWLHQW¶V SURJUHVV DQG UHVSRQVH WR
treatment was challenged. (29). 
 
The need to involve dementia-specific support at the outset was emphasised by caregivers, 
with one study highlighting the example of a designated dementia nurse and biographical tool 
which was used in clinic to enhance support for patients with dementia (27). Two studies 
highlighted the need for HCP familiarity and how this was accomplished by using a 
designated HCP to coordinate care (28, 29). This avoided the need for repetitive recall of the 
patients' medical history and unnecessary frustration and anxiety for the patient (29). 
McWilliams and colleagues reported a positive scenario where the caregiver found it helpful 
to have the HCP repeat the information to her husband and pay more attention to the pacing 
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of the consultation, which led to a positive experience for both the caregiver and the person 
with dementia (30). 
3.2.2. TREATMENT DECISION-MAKING DISCUSSIONS, INFORMATION 
AND COMMUNICATION NEEDS 
 
Weighing up the pros and cons of treatment options for a person living with dementia may 
not only involve the caregiver; the HCP and patients themselves may also be involved in 
making these decisions. Five studies reported on the direct influence of dementia on cancer 
treatment discussions (26-30).  
 
For people with dementia or memory issues, extra time may be needed to communicate 
information about their cancer diagnosis and treatment options. One study highlighted a 
scenario where a caregiver relayed his PRWKHU¶Vlack of awareness of her diagnosis due to her 
dementia, and relayed a scenario of conveying the diagnosis to his mother using a µFUHDWLYH
VWUDWHJ\¶ and metaphors (30). Caregivers in Witham anGFROOHDJXHV¶ study also described the 
QHHGIRUµFomplex communication strategies¶ (29). Examples of this in other studies included 
taking more time to discuss options (30), µVORZLQJGRZQ¶ LQIRUPDWLRQ delivery and using a 
change in language to communicate complex treatment information (28).  
 
In situations where patients lacked capacity, the caregiver gathered treatment information and 
negotiated on behalf of the patient (27, 29), acting µDVD UHOLDEOHPHVVHQJHU¶ RU µrelayer of 
LQIRUPDWLRQ¶ between the HCP and the patient (28, 30). In another study, one caregiver 
reflected on this role in assisting the HCP during hiVZLIH¶VFDQFHULQYHVWLJDWLRQVdescribing 
a scenario where he would stay in the room to reassure his wife, and would break down 
complicated instructions from the HCP to his spouse (30). 
 
In respect to treatment decisions FDUHJLYHUV LQ6P\WK¶V study expressed the view that side 
effects would have an influence on the pursuit of any hypothetical cancer treatments, with 
some only willing to opt for active treatments when the side effects were less severe (26). It 
was noted in another study, however, that comprehensive treatment information on the risks 
and side-effects were not always fully explained to caregivers, and often misunderstood (28). 
In respect to the level of information received, some caregivers reported receiving enough 
verbal information, such as leaflets, but others described feeling they had to seek information 
for themselves post-consultation (30). 
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6P\WK¶V study of current practices in breast cancer treatment found that dementia severity 
had an impact on the decision-making of caregivers towards screening and hypothetical 
treatment scenarios (26). For caregivers of women with severe dementia, only comfort care 
was suggested, whilst in women with mild-moderate dementia, caregivers were more likely 
WR FKRRVH W\SLFDOO\ µDJJUHVVLYH¶ WUHDWPHQWV ,W ZDV DOVR QRWHG WKDW FDUHJLYHU WUHDWPHQW
decisionV ZKLOH K\SRWKHWLFDO GLG QRW DOZD\V WDNH LQWR FRQVLGHUDWLRQ WKH SDWLHQW¶V
comorbidities and life expectancy (26).  
 
Courtier and colleagues highlighted that people with dementia are likely to receive less 
treatment than patients without dementia (27). Reasons for this include the implications of 
dementia on life expectancy and the inability to tolerate treatments with complex regimens 
and severe side effects (27). McWilliams and colleagues also noted that the combination of 
cognition and communication impairments had a direct influence on treatment options, 
particularly the potential for side effects (28) and the impact on quality of life for the person 
living with dementia was noted in another study (30).  
 
The impact of dementia on treatment was not always considered by HCPs, and there was 
little regard for how treatment pathways could be adapted to PHHWWKHSDWLHQW¶VQHHGV (29). In 
this context, Witham and associates posit that the adaption of treatment regimens is needed 
for this population (29). When discussing treatment options with the HCP, caregivers 
reported unmet information needs; whereby information was not always communicated in an 
appropriate format, nor adapted in a way that was specific to patients with a cancer-dementia 
diagnosis (28).  
3.2.3. THE ROLE OF THE CAREGIVER AND THE CAREGIVER-PATIENT 
RELATIONSHIP 
 
The caregiver plays an important role in cancer treatment decision-making, mainly by 
facilitating discussion around the treatment and care preferences of people who lack capacity. 
All six studies recruited caregivers (25-30).  
 
In the study led by McWilliams and colleagues, caregivers played a role in both uncovering 
V\PSWRPV DQG VHHNLQJ KHOS IRU WKH SHUVRQ ZLWK GHPHQWLD GHVFULELQJ WKHVH DV µGHWHFWLYH
VWRULHV¶(30). In other studies, family and informal caregivers were described as the key to a 
successful consultation (27, 28) and best placed to represent the voice of the patient; 
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particularly in scenarios where the caregiver knew the patient well (27). This point was also 
echoed in McWilliams and colleagues¶ study, whereby the researcher reflected on the 
significance of the µORQJLWXGLQDO DQG ELRJUDSKLFDO¶ knowledge of the caregiver in research 
interviews (30). In some cases however, Witham and colleagues noted that patients were 
prone to downplaying the importance of the caregiver role and that this in turn meant that 
advocating on behalf of the patient could be challenging for their relatives (29).  
 
Caregivers are often relied upon to ensure that patients adhere safely to treatment and monitor 
any untoward side-effects (27). New treatment regimens, additional appointments and 
assisted home care needs may increase the demand on caregivers themselves, such as 
radiotherapy treatment, which may require repeated trips to hospital (30). These additional 
burdens on the caregiver were not always considered during treatment discussions (28), and 
HCPs were not always found to enquire about the needs of the caregiver (27). As a result, 
some FDUHJLYHUVUHSRUWHGIHHOLQJH[FOXGHGIURPWKHSDWLHQW¶VFDQFHUMRXUQH\(29). Caregivers 
in the same study felt that their role was often marginalized by the HCP; describing a 
scenario where their knowledge and judgment of the person with dementia was questioned by 
the HCP (29). 
 
It is posited that the caregiver-patient relationship itself may have a direct impact on the 
outcome of treatment decisions. Courtier and colleagues noted that in scenarios where the 
caregiver did not know the patient personally, µPHPRU\ORVVDFWHGDVDEDUULHUWRDVXFFHVVIXO
FRQVXOWDWLRQ¶ (27). The HCPs' reliance on informal and family caregivers was also 
highlighted by McWilliams and colleagues, who reported difficulties where patients with 
dementia had attended clinic with a caregiver who had limited knowledge and no relationship 
to the patient (28). 
 
People living with dementia often rely on caregivers to make decisions on their behalf. The 
+&3VLQ&RXUWLHU¶V paper were happy to conduct consultations with the caregiver taking the 
lead decision-making role, however this could sometimes have the unintended effect of 
disguising memory difficulties experienced by the person with dementia, unless it was 
disclosed, or made known to the clinician (27). However, Harrison Dening and colleagues 
reported that the dependency on caregivers to interpret patient decisions might be misplaced. 
In their study of hypothetical treatment scenarios, caregivers and patients did not always 
agree consistently on future treatment scenarios. Where asked about advanced cancer 
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treatment scenarios, patients with dementia had a preference for antibiotic treatment (47%) 
over CPR (30%) and tube feeding (37%). Within dyads there was a low level of agreement 
(25).  
4. DISCUSSION 
 
The key findings from this review highlight the lack of dementia specific support at the start 
of the cancer journey. People with dementia require additional support, and time for 
discussion, when planning treatment and attending appointments. While caregivers are often 
relied upon for their biographical knowledge, their support and information needs are not 
always considered by HCPs. These findings show that there is a missed opportunity for 
allowing caregivers a more active role in consultations and treatment decision-making for 
people with dementia and cancer. 
 
The main aim of this review was to explore how caregivers are involved in making treatment 
decisions for older people living dementia who receive a new diagnosis of cancer. This aim, 
however, was only partially achieved. One reason for this was the limited scope of studies 
that have focused specifically on caregiving for this sub-population. The intention was to 
review studies that explored treatment decision-making in the context of early stage cancer, 
with a focus on life-sustaining treatment, rather than end of life treatment decision-making. 
However, very few studies could be found in the initial scoping stages of the review. 
 
Although the search strategy focused on studies that recruited caregivers, one theme 
emerging from this review is the notion that discussions around memory, behavioral and 
psychological symptoms (BPSD) of dementia are absent from the cancer consultation. It is 
therefore unclear if these symptoms are taken into account when discussing the suitability of 
different treatments. The studies included in this review have highlighted some of the barriers 
to navigating health care appointments and treatment discussions. These issues are consistent 
with the wider literature, which highlights the complexities involved with HCP encounters 
for people with dementia (31). 
 
While some of the studies included in this review have explored the impact of dementia on 
treatment decision-making, there has been insufficient focus on how caregivers make 
treatment decisions, the type of information that caregivers would prefer to receive, and how 
  
This article is protected by copyright. All rights reserved. 
advance decisions are used in the decision-making discussions. Only one study made 
UHIHUHQFHWRWKHWKHPHRIPDLQWDLQLQJWKHµSUH-GHPHQWLD¶SUHIHUHQFHVRIpeople with dementia 
in respect to breast screening, however these preferences were not upheld as the severity of 
dementia increased (26).   
 
A significant finding from the literature was the lack of knowledge and dementia awareness 
amongst health care professionals. There may be other complex issues influencing the 
treatment decision that have not been fully addressed. This may include the age, frailty, 
mobility and independence of the person with dementia.  
 
4.1.STUDY LIMITATIONS 
 
The small number of studies in this review highlights the need for more research in to the 
cancer treatment decision-making experiences of older people with dementia and their 
caregivers. One explanation for the lack of studies in this area may be that this population is 
difficult to access and obtain consent to participate in research studies. The settings for the 
studies included were cancer clinics (27-30), dementia registries (26) and memory clinics 
(25), which are key settings for capturing patients with dementia or their caregivers. Despite 
this, recruitment was still challenging. Two studies reflected on the challenges in identifying 
participants, the consent process and small number of eligible participants (25, 27). Courtier 
and colleagues reflected on how their study sample was smaller than expected (27), hinting at 
underlying inequality in access to cancer services in those with a dementia diagnosis. 
 
Of the studies included in this review, the level of cognitive impairment 
(mild/moderate/severe) and functioning of patients was not always clear, except in the two 
studies, which reported dementia subtypes (29, 30). It is therefore not possible to make 
generalizations regarding all older patients with dementia. It is not possible to make any 
assumptions about the experiences of caregivers for people with mild dementia verses severe 
dementia, and more research is needed to translate findings to a range of cancer populations 
(27). 
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4.2.CLINICAL IMPLICATIONS 
 
The involvement of people living with dementia in research requires a high level of ethical 
scrutiny. In addition, there are strict safeguarding policies in place for any research involving 
participants with limited cognitive capacity. The small numbers of participants included in 
these papers hint at the complexities involved in recruitment and the additional support that 
caregivers and patients in this population may need to participate in research.  
 
Low recruitment may also be linked to the sensitive nature of making decisions for another 
person, at what is undoubtedly a highly emotive time in their cancer journey. Receiving a 
cancer diagnosis can be psychologically stressful for both people with dementia and their 
caregivers. Therefore, deciding on the right time to approach caregivers might affect their 
willingness to take part in research. For this reason, many researchers may be cautious about 
causing distress, and caregivers may gate-keep access to people with dementia (32). 
 
The themes identified in this review are consistent with the background context of dementia-
cancer research. This review has identified a clear need to increase specialist dementia 
support for both the patient and caregivers from the initial consultation and throughout the 
cancer care pathway. Ensuring that HCPs have appropriate training and can identify memory, 
behavioral and cognition problems will mean that any advice or treatment recommended is 
tailored appropriately to the patient. More specific information tailored towards caregivers 
and people living with dementia is also needed in order to optimize treatment decision-
making.  
5. CONCLUSION 
 
Cancer treatment decision-making for older people with dementia remains a complex issue. 
With an ever-increasing aged population, this research raises concerns about the management 
of people with cancer who lack mental capacity and the support needs for those who are 
directly involved in making difficult choices on behalf of the people they care for. Further 
exploration of caregiver experiences in this context is needed. 
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TABLE 1: STUDIES INCLUDED IN THE REVIEW  
 
Author(s) 
and year of 
publication 
 
Study 
population 
and setting 
Objective(s) Design Method Summary of 
themes 
MMAT 
score  
Smyth 
(2009) 
Family 
caregivers 
(n=23) of 
women with 
dementia. 
 
Recruited 
from 
$O]KHLPHU¶V
Disease 
Research 
Center 
Registry, 
USA. 
 
To explore 
breast 
screening 
and 
treatment 
decision-
making in 
older women 
with 
dementia. 
 
Qualitative. Semi- 
structured 
telephone 
interviews. 
 
Thematic 
Analysis. 
(1) Perceived 
importance of 
regular 
screening 
mammograms. 
(2) Perceived 
appropriateness 
of breast cancer 
treatment 
options. 
 
75% 
Harrison 
Dening et al 
(2016) 
Dyads of 
family 
caregivers 
and people 
with 
dementia 
(n=60). 
 
Recruited 
from 
memory 
clinics in 
UK. 
To explore 
choices and 
preferences 
of caregivers 
and people 
with 
dementia. 
Quantitative. 
Cross 
sectional 
study. 
Semi- 
structured 
interviews. 
 
Descriptive 
statistics. 
(1) Treatment 
choices and 
carer agreement 
in prediction. 
(2) Uncertainty. 
(3) Carer 
burden, 
distress, and 
quality of 
relationship.  
 
75% 
Courtier et 
al (2016) 
Caregivers 
and people 
with 
dementia. 
 
33 
consultations 
observed. 10 
consultations 
recorded, 16 
interviews 
(n=6 patient-
caregiver 
dyads; n=1 
lone patient; 
n=5 staff). 
 
Medical 
record 
review 
(n=338). 
 
Recruited 
from 4 
outpatient 
To observe 
the 
management 
of patients 
with 
dementia, 
memory loss 
and cancer. 
Explore the 
needs and 
preferences 
of outpatient 
cancer 
services, 
Qualitative 
Case Study 
Design. 
Retrospective 
case note 
review; 
observation; 
interviews; 
recoded 
consultations. 
 
Framework 
Analysis. 
(1). Memory 
and the cancer 
consultation. 
(2) Staff 
attitudes. (3) 
Management 
Approach. (4) 
Carer role. 
 
75% 
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clinics in 1 
UK cancer 
center. 
 
McWilliams 
et al (2018) 
Informal 
caregivers 
(n=9); 
people with 
dementia-
cancer 
(n=10), and 
oncology 
HCPs 
(n=12). 
 
Recruited 
from a 
regional NW 
England 
Cancer 
Centre, UK.  
To explore 
the 
information 
needs and 
experiences 
of 
caregivers, 
patients with 
dementia-
cancer and 
oncology 
HCPs. 
Qualitative. 
Cross 
Sectional 
Design. 
Semi-
structured 
face-to-face 
interviews. 
 
Thematic 
analysis. 
(1) Leading up 
to the cancer 
consultation. 
(2) 
Communicating 
clinically 
relevant 
information. (3) 
Adjustments to 
cancer care. (4) 
After cancer 
treatment 
finishes. 
 
100% 
Witham et 
al (2018) 
Informal 
family 
caregivers 
(n=7).  
 
Recruited 
from a 
psycho-
oncology 
unit at a 
regional 
cancer 
centre, UK. 
To explore 
the 
experiences 
of caregivers 
of relatives 
with cancer 
and 
dementia. 
Qualitative. 
Narrative 
Approach.   
Semi-
structured 
face-to-face 
interviews 
using 
interview 
guide.  
 
Analytical 
Framework.  
(1) 
Communication 
with Health 
Care 
Professionals: 
Maintaining 
carer identity. 
(2) Decision 
making and 
maintaining 
personhood. (3) 
Negotiating 
cancer care. 
100% 
McWilliams 
et al (2018) 
Family 
caregivers 
(n=9); 
people with 
dementia-
cancer 
(n=10). 
 
Recruited 
from a 
regional NW 
England 
Cancer 
Centre, UK. 
To explore 
the decision-
making and 
treatment 
options for 
people with 
dementia-
cancer, and 
their family 
caregivers. 
Qualitative. 
Exploratory.  
Semi-
structured 
face-to-face 
interviews. 
 
Thematic 
approach. 
(1) Reaching a 
diagnosis of 
cancer; (2) 
Adjusting to the 
cancer 
diagnosis when 
living with 
dementia; (3) 
Weighing up 
the cancer 
treatment 
options; (4) 
Undergoing 
cancer 
treatment. 
100% 
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Figure 1. PRISMA Flow Diagram 
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Additional records identified 
through other sources 
(n =  3) 
Records after duplicates removed 
(n = 1761) 
Records screened 
(n = 1761) 
Records excluded 
(n = 1725) 
Full-text articles assessed 
for eligibility 
(n = 36) 
Full-text articles 
excluded, with reasons 
(n = 30) 
x Caregiver not in the 
sample (n=5) 
x Case study (n=6) 
x Review (n=2) 
x Decision-making not 
the focus (n=2) 
x Dementia decisions 
absent (n=7) 
x Cancer decisions 
absent (n=2) 
x End of life decisions 
only (n=2) 
x Abstract only (n=4) 
Studies included in 
qualitative synthesis 
(n = 6) 
